Westpac Banking Corp’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,249
Closed -$441K 486
2024
Q4
$441K Buy
1,249
+76
+6% +$26.8K 0.03% 283
2024
Q3
$420K Buy
+1,173
New +$420K 0.03% 291
2024
Q2
Sell
-1,178
Closed -$271K 489
2024
Q1
$271K Buy
+1,178
New +$271K 0.02% 314
2023
Q4
Sell
-3,200
Closed -$723K 521
2023
Q3
$723K Buy
+3,200
New +$723K 0.05% 264
2023
Q2
Sell
-33,425
Closed -$7.49M 766
2023
Q1
$7.49M Buy
33,425
+24,072
+257% +$5.39M 0.1% 260
2022
Q4
$2.6M Buy
+9,353
New +$2.6M 0.04% 459
2019
Q2
Sell
-8,892
Closed -$1.04M 743
2019
Q1
$1.04M Hold
8,892
0.02% 535
2018
Q4
$968K Buy
8,892
+779
+10% +$84.8K 0.02% 582
2018
Q3
$1.04M Sell
8,113
-5,862
-42% -$750K 0.02% 534
2018
Q2
$1.58M Hold
13,975
0.03% 429
2018
Q1
$1.57M Buy
13,975
+11,458
+455% +$1.29M 0.03% 419
2017
Q4
$372K Hold
2,517
0.01% 658
2017
Q3
$295K Sell
2,517
-129
-5% -$15.1K 0.01% 757
2017
Q2
$343K Sell
2,646
-74,954
-97% -$9.72M 0.01% 782
2017
Q1
$10.5M Buy
77,600
+36,072
+87% +$4.88M 0.08% 241
2016
Q4
$8.11M Sell
41,528
-39,045
-48% -$7.62M 0.08% 272
2016
Q3
$9.51M Sell
80,573
-81,490
-50% -$9.62M 0.1% 197
2016
Q2
$15.1M Buy
162,063
+65,544
+68% +$6.12M 0.17% 146
2016
Q1
$10.8M Sell
96,519
-93,375
-49% -$10.4M 0.12% 184
2015
Q4
$29.7M Buy
189,894
+98,395
+108% +$15.4M 0.33% 72
2015
Q3
$12M Buy
91,499
+91,187
+29,227% +$12M 0.13% 150
2015
Q2
$54.3K Buy
+312
New +$54.3K ﹤0.01% 798
2014
Q4
Sell
-58,897
Closed -$7.58M 972
2014
Q3
$7.58M Sell
58,897
-11,000
-16% -$1.42M 0.07% 248
2014
Q2
$6.19M Sell
69,897
-16,100
-19% -$1.42M 0.06% 302
2014
Q1
$8.09M Buy
85,997
+11,200
+15% +$1.05M 0.09% 230
2013
Q4
$8.46M Buy
74,797
+19,200
+35% +$2.17M 0.1% 226
2013
Q3
$4.38M Buy
55,597
+9,900
+22% +$781K 0.05% 315
2013
Q2
$2.78M Buy
+45,697
New +$2.78M 0.04% 360